Originally published by our sister publication Infectious Disease Special Edition
The FDA expanded the indication to remdesivir (Veklury, Gilead) for use in COVID-19 patients with severe renal impairment, including those on dialysis.
With this approval, remdesivir is now the first and only approved antiviral COVID-19 treatment that can be used across all stages of renal disease. About 37 million people in the United States are estimated to have chronic kidney disease (CKD) and at increased